Sonnet Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $18 | $37 |
Gross Profit | -21 | -20 | -1 | 17 |
EBITDA | -3,507 | -3,848 | -1,258 | -3,580 |
EBIT | -3,528 | -3,868 | -1,278 | -3,600 |
Net Income | -3,505 | 365 | -1,168 | -3,676 |
Net Change In Cash | 0 | 0 | 18 | 37 |
Free Cash Flow | -3,081 | 723 | -3,091 | -4,729 |
Cash | 3,554 | 3,786 | 3,021 | 2,274 |
Basic Shares | 5,037 | 4,617 | 3,797 | 1,757 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $147 | $349 | $483 | $0 |
Gross Profit | -11,666 | 256 | -16,150 | -58 |
EBITDA | -18,716 | -29,576 | -24,992 | -24,237 |
EBIT | -18,792 | -29,669 | -25,087 | -24,296 |
Net Income | -18,832 | -29,774 | -25,005 | -31,060 |
Net Change In Cash | 147 | 349 | 483 | 0 |
Free Cash Flow | -21,785 | -28,583 | -22,555 | -15,690 |
Cash | 2,274 | 3,052 | 27,622 | 7,349 |
Basic Shares | 1,038 | 197 | 79 | 30 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.70 |
2024-03-31 | $0.07 |
2023-12-31 | -$0.31 |
2023-09-30 | -$2.09 |
